Effect of HMP on Diabetic Microangiopaemia in T2DM
The study mainly investigates the therapeutic effect of Heart-Protecting Musk Pill (HMP) on patients with diabetic microangiopathy.
According to the indicators of diabetic nephropathy (DN), diabe ...
: Diabetes Mellitus, Type 2
Implementing HEARTS in Guatemala
The HEARTS Technical Package was developed by the World Health Organization to address the implementation gap of cardiovascular disease prevention in low- and middle-income countries.
Guatemala i ...
: Diabetes Mellitus, Type 2
Aspirin Twice a Day in Patients With Diabetes and Acute Coronary Syndrome
To compare treatment with Aspirin Protect� twice a day (100 mg in the morning and 100 mg in the evening) versus Aspirin Protect� 100 mg once per day on a composite end-point of ischemic events in diab ...
: Diabetes Mellitus